{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:54:30Z","timestamp":1792742070010,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2021-NR059744"],"award-info":[{"award-number":["RS-2021-NR059744"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2020-NR049556"],"award-info":[{"award-number":["RS-2020-NR049556"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT","doi-asserted-by":"crossref","award":["RS-2025-00522567"],"award-info":[{"award-number":["RS-2025-00522567"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2025-25397788"],"award-info":[{"award-number":["RS-2025-25397788"]}],"id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2024-00461177"],"award-info":[{"award-number":["RS-2024-00461177"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatocellular carcinoma (HCC) remains highly lethal, and emerging therapeutic strategies increasingly focus on harnessing ferroptosis to overcome treatment resistance. However, ferroptosis resistance has emerged as a major barrier to these approaches, highlighting the need to identify metabolic cues in the tumor microenvironment that drive this evasion. Here, we identify lactate as a critical metabolite that mediates detrimental metabolic crosstalk between HCC cells and hepatic stellate cells (HSCs), coupling this interaction to pyrimidine biosynthesis and enhanced extracellular matrix (ECM) production within the tumor microenvironment. We show that tumor-derived lactate activates mechanistic target of rapamycin complex 1 (mTORC1)\u2013carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (CAD) signaling, enhancing de novo pyrimidine biosynthesis and pre-ribosomal RNA synthesis, thereby promoting ECM protein translation. The resulting ECM deposition drives Yes-associated protein (YAP)\/TEA domain family member (TEAD)-dependent upregulation of the cystine\/glutamate antiporter (xCT) in HCC cells, conferring marked resistance to sorafenib-induced ferroptosis. Inhibition of dihydroorotate dehydrogenase, the rate-limiting enzyme in pyrimidine synthesis, disrupts ECM production and restores ferroptosis sensitivity in vitro and in vivo. Clinical data further support these findings, indicating that phosphorylated CAD (p-CAD) levels in HSCs are associated with both poor prognosis and lactate-associated ECM enrichment in HCC patients. Collectively, our study identifies lactate-fueled pyrimidine biosynthesis as a key driver of ECM remodeling and ferroptosis resistance in HCC. Targeting this metabolic axis offers a promising therapeutic strategy to overcome ECM-mediated drug resistance and improve outcomes with ferroptosis-based HCC therapies.<\/jats:p>","DOI":"10.1186\/s43556-026-00450-3","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:37:05Z","timestamp":1776407825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lactate-driven pyrimidine synthesis promotes ferroptosis resistance in hepatocellular carcinoma"],"prefix":"10.1186","volume":"7","author":[{"given":"Mun-Ju","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung Kuk","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghilsuk","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihyang","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Hwa","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Kyu","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Kyung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keun-Gyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"450_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00709","volume":"8","author":"AE Barry","year":"2020","unstructured":"Barry AE, Baldeosingh R, Lamm R, Patel K, Zhang K, Dominguez DA, et al. Hepatic stellate cells and hepatocarcinogenesis. Front Cell Dev Biol. 2020;8:709. https:\/\/doi.org\/10.3389\/fcell.2020.00709.","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"450_CR2","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1158\/0008-5472.CAN-11-3317","volume":"72","author":"C Coulouarn","year":"2012","unstructured":"Coulouarn C, Corlu A, Glaise D, Guenon I, Thorgeirsson SS, Clement B. Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma. Cancer Res. 2012;72(10):2533\u201342. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3317.","journal-title":"Cancer Res"},{"key":"450_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.biomaterials.2016.02.003","volume":"86","author":"JM Aamodt","year":"2016","unstructured":"Aamodt JM, Grainger DW. Extracellular matrix-based biomaterial scaffolds and the host response. Biomaterials. 2016;86:68\u201382. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.02.003.","journal-title":"Biomaterials"},{"issue":"1","key":"450_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022;21(1):47. https:\/\/doi.org\/10.1186\/s12943-022-01530-y.","journal-title":"Mol Cancer"},{"key":"450_CR5","doi-asserted-by":"publisher","unstructured":"Li X, Yang Y, Zhang B, Lin X, Fu X, An Y, et al. Lactate metabolism in human health and disease. Signal Transduct Target Ther. 2022;7(1):305.https:\/\/doi.org\/10.1038\/s41392-022-01151-3","DOI":"10.1038\/s41392-022-01151-3"},{"issue":"23","key":"450_CR6","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1113\/jphysiol.2009.178350","volume":"587","author":"GA Brooks","year":"2009","unstructured":"Brooks GA. Cell-cell and intracellular lactate shuttles. J Physiol. 2009;587(23):5591\u2013600. https:\/\/doi.org\/10.1113\/jphysiol.2009.178350.","journal-title":"J Physiol"},{"issue":"1","key":"450_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12986-022-00687-z","volume":"19","author":"X Xue","year":"2022","unstructured":"Xue X, Liu B, Hu J, Bian X, Lou S. The potential mechanisms of lactate in mediating exercise-enhanced cognitive function: a dual role as an energy supply substrate and a signaling molecule. Nutr Metab (Lond). 2022;19(1):52. https:\/\/doi.org\/10.1186\/s12986-022-00687-z.","journal-title":"Nutr Metab (Lond)"},{"issue":"2","key":"450_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tibs.2018.10.011","volume":"44","author":"L Ippolito","year":"2019","unstructured":"Ippolito L, Morandi A, Giannoni E, Chiarugi P. Lactate: a metabolic driver in the tumour landscape. Trends Biochem Sci. 2019;44(2):153\u201366. https:\/\/doi.org\/10.1016\/j.tibs.2018.10.011.","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"450_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12272-023-01431-8","volume":"46","author":"JK Byun","year":"2023","unstructured":"Byun JK. Tumor lactic acid: a potential target for cancer therapy. Arch Pharm Res. 2023;46(2):90\u2013110. https:\/\/doi.org\/10.1007\/s12272-023-01431-8.","journal-title":"Arch Pharm Res"},{"key":"450_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.06.013","author":"HTA Rho","year":"2023","unstructured":"Rho HTA, Chronis C, Hay N. Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis. Cell Metab. 2023. https:\/\/doi.org\/10.1016\/j.cmet.2023.06.013.","journal-title":"Cell Metab"},{"key":"450_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.02.005","volume":"35","author":"A Siddiqui","year":"2020","unstructured":"Siddiqui A, Ceppi P. A non-proliferative role of pyrimidine metabolism in cancer. Mol Metab. 2020;35:100962. https:\/\/doi.org\/10.1016\/j.molmet.2020.02.005.","journal-title":"Mol Metab"},{"key":"450_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.684961","volume":"11","author":"W Wang","year":"2021","unstructured":"Wang W, Cui J, Ma H, Lu W, Huang J. Targeting pyrimidine metabolism in the era of precision cancer medicine. Front Oncol. 2021;11:684961. https:\/\/doi.org\/10.3389\/fonc.2021.684961.","journal-title":"Front Oncol"},{"issue":"39","key":"450_CR13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2202157119","volume":"119","author":"F Liu","year":"2022","unstructured":"Liu F, Gai X, Wu Y, Zhang B, Wu X, Cheng R, et al. Oncogenic \u03b2-catenin stimulation of AKT2\u2013CAD-mediated pyrimidine synthesis is targetable vulnerability in liver cancer. Proc Natl Acad Sci U S A. 2022;119(39):e2202157119. https:\/\/doi.org\/10.1073\/pnas.2202157119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"450_CR14","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/s0891-5849(00)00239-2","volume":"28","author":"C Beuneu","year":"2000","unstructured":"Beuneu C, Auger R, Loffler M, Guissani A, Lemaire G, Lepoivre M. Indirect inhibition of mitochondrial dihydroorotate dehydrogenase activity by nitric oxide. Free Radic Biol Med. 2000;28(8):1206\u201313. https:\/\/doi.org\/10.1016\/s0891-5849(00)00239-2.","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"450_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165759","volume":"1866","author":"S Boukalova","year":"2020","unstructured":"Boukalova S, Hubackova S, Milosevic M, Ezrova Z, Neuzil J, Rohlena J. Dihydroorotate dehydrogenase in oxidative phosphorylation and cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2020;1866(6):165759. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165759.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"23","key":"450_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e39491","volume":"10","author":"S Fu","year":"2024","unstructured":"Fu S, Xu J, Wang C, Zhang C, Li C, Xie W, et al. Cancer specific up-regulated lactate genes associated with immunotherapy resistance in a pan-cancer analysis. Heliyon. 2024;10(23):e39491. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39491.","journal-title":"Heliyon"},{"key":"450_CR17","doi-asserted-by":"publisher","unstructured":"Kitamura F, Semba T, Yasuda-Yoshihara N, Yamada K, Nishimura A, Yamasaki J, et al. Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer. JCI Insight. 2023;8(20).https:\/\/doi.org\/10.1172\/jci.insight.163022","DOI":"10.1172\/jci.insight.163022"},{"key":"450_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01143","volume":"9","author":"KG de la Cruz-L\u00f3pez","year":"2019","unstructured":"de la Cruz-L\u00f3pez KG, Castro-Mu\u00f1oz LJ, Reyes-Hern\u00e1ndez DO, Garc\u00eda-Carranc\u00e1 A, Manzo-Merino J. Lactate in the regulation of tumor microenvironment and therapeutic approaches. Front Oncol. 2019;9:1143. https:\/\/doi.org\/10.3389\/fonc.2019.01143.","journal-title":"Front Oncol"},{"issue":"3","key":"450_CR19","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccell.2016.08.005","volume":"30","author":"L Brisson","year":"2016","unstructured":"Brisson L, Ba\u0144ski P, Sboarina M, Dethier C, Danhier P, Fontenille MJ, et al. Lactate dehydrogenase B controls lysosome activity and autophagy in cancer. Cancer Cell. 2016;30(3):418\u201331. https:\/\/doi.org\/10.1016\/j.ccell.2016.08.005.","journal-title":"Cancer Cell"},{"key":"450_CR20","doi-asserted-by":"publisher","unstructured":"Liu N, Luo J, Kuang D, Xu S, Duan Y, Xia Y, et al. Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2alpha-mediated tumor progression. J Clin Invest. 2019;129(2):631\u201346.https:\/\/doi.org\/10.1172\/JCI123027","DOI":"10.1172\/JCI123027"},{"issue":"1","key":"450_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12079-020-00599-8","volume":"15","author":"R Nikooie","year":"2021","unstructured":"Nikooie R, Moflehi D, Zand S. Lactate regulates autophagy through ROS-mediated activation of ERK1\/2\/m-TOR\/p-70S6K pathway in skeletal muscle. J Cell Commun Signal. 2021;15(1):107\u201323. https:\/\/doi.org\/10.1007\/s12079-020-00599-8.","journal-title":"J Cell Commun Signal"},{"key":"450_CR22","doi-asserted-by":"publisher","unstructured":"Byun JK, Park M, Yun JW, Lee J, Kim JS, Cho SJ, et al. Oncogenic KRAS signaling activates mTORC1 through COUP-TFII-mediated lactate production. EMBO Rep. 2019;20(6).https:\/\/doi.org\/10.15252\/embr.201847451","DOI":"10.15252\/embr.201847451"},{"issue":"15","key":"450_CR23","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41388-023-02641-6","volume":"42","author":"B Liu","year":"2023","unstructured":"Liu B, Zhang J, Meng X, Xie SM, Liu F, Chen H, et al. HDAC6-G3BP2 promotes lysosomal-TSC2 and suppresses mTORC1 under ETV4 targeting-induced low-lactate stress in non-small cell lung cancer. Oncogene. 2023;42(15):1181\u201395. https:\/\/doi.org\/10.1038\/s41388-023-02641-6.","journal-title":"Oncogene"},{"issue":"2","key":"450_CR24","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.celrep.2016.09.020","volume":"17","author":"M Marabita","year":"2016","unstructured":"Marabita M, Baraldo M, Solagna F, Ceelen JJM, Sartori R, Nolte H, et al. S6K1 is required for increasing skeletal muscle force during hypertrophy. Cell Rep. 2016;17(2):501\u201313. https:\/\/doi.org\/10.1016\/j.celrep.2016.09.020.","journal-title":"Cell Rep"},{"key":"450_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1036543","volume":"12","author":"M Luo","year":"2022","unstructured":"Luo M, Zhu J, Ren J, Tong Y, Wang L, Ma S, et al. Lactate increases tumor malignancy by promoting tumor small extracellular vesicles production via the GPR81-cAMP-PKA-HIF-1\u03b1 axis. Front Oncol. 2022;12:1036543. https:\/\/doi.org\/10.3389\/fonc.2022.1036543.","journal-title":"Front Oncol"},{"key":"450_CR26","doi-asserted-by":"publisher","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380.https:\/\/doi.org\/10.1038\/s41586-019-1678-1","DOI":"10.1038\/s41586-019-1678-1"},{"key":"450_CR27","doi-asserted-by":"publisher","unstructured":"Dong M, Zhang Y, Chen M, Tan Y, Min J, He X, et al. ASF1A-dependent P300-mediated histone H3 lysine 18 lactylation promotes atherosclerosis by regulating EndMT. Acta Pharm Sin B. 2024;14(7):3027\u201348.https:\/\/doi.org\/10.1016\/j.apsb.2024.03.008","DOI":"10.1016\/j.apsb.2024.03.008"},{"key":"450_CR28","doi-asserted-by":"publisher","unstructured":"Wang C, Cigliano A, Jiang L, Li X, Fan B, Pilo MG, et al. 4EBP1\/eIF4E and p70S6K\/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice. Hepatology. 2015;61(1):200\u201313.https:\/\/doi.org\/10.1002\/hep.27396","DOI":"10.1002\/hep.27396"},{"issue":"22","key":"450_CR29","doi-asserted-by":"publisher","first-page":"7680","DOI":"10.1016\/j.bmc.2009.09.045","volume":"17","author":"L Coudray","year":"2009","unstructured":"Coudray L, Pennebaker AF, Montchamp JL. Synthesis and in vitro evaluation of aspartate transcarbamoylase inhibitors. Bioorg Med Chem. 2009;17(22):7680\u20139. https:\/\/doi.org\/10.1016\/j.bmc.2009.09.045.","journal-title":"Bioorg Med Chem"},{"key":"450_CR30","doi-asserted-by":"publisher","unstructured":"Mullen NJ, Shukla SK, Thakur R, Kollala SS, Wang D, Chaika N, et al. DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation. Elife. 2024;12.https:\/\/doi.org\/10.7554\/eLife.87292","DOI":"10.7554\/eLife.87292"},{"key":"450_CR31","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.153836","author":"TK Olsen","year":"2022","unstructured":"Olsen TK, Dyberg C, Embaie BT, Alchahin A, Milosevic J, Ding J, et al. DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma. JCI Insight. 2022. https:\/\/doi.org\/10.1172\/jci.insight.153836.","journal-title":"JCI Insight"},{"issue":"1","key":"450_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-021-00250-z","volume":"9","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Tao L, Zhou X, Zuo Z, Gong J, Liu X, et al. DHODH and cancer: promising prospects to be explored. Cancer Metab. 2021;9(1):22. https:\/\/doi.org\/10.1186\/s40170-021-00250-z.","journal-title":"Cancer Metab"},{"issue":"11","key":"450_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009117","volume":"16","author":"MC Lafita-Navarro","year":"2020","unstructured":"Lafita-Navarro MC, Venkateswaran N, Kilgore JA, Kanji S, Han J, Barnes S, et al. Inhibition of the de novo pyrimidine biosynthesis pathway limits ribosomal RNA transcription causing nucleolar stress in glioblastoma cells. PLoS Genet. 2020;16(11):e1009117. https:\/\/doi.org\/10.1371\/journal.pgen.1009117.","journal-title":"PLoS Genet"},{"key":"450_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/biom8040123","author":"M Aubert","year":"2018","unstructured":"Aubert M, O\u2019Donohue MF, Lebaron S, Gleizes PE. Pre-ribosomal RNA processing in human cells: from mechanisms to congenital diseases. Biomolecules. 2018. https:\/\/doi.org\/10.3390\/biom8040123.","journal-title":"Biomolecules"},{"issue":"1","key":"450_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31418-w","volume":"13","author":"M Pan","year":"2022","unstructured":"Pan M, Zorbas C, Sugaya M, Ishiguro K, Kato M, Nishida M, et al. Glutamine deficiency in solid tumor cells confers resistance to ribosomal RNA synthesis inhibitors. Nat Commun. 2022;13(1):3706. https:\/\/doi.org\/10.1038\/s41467-022-31418-w.","journal-title":"Nat Commun"},{"key":"450_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071826","author":"D Bekric","year":"2022","unstructured":"Bekric D, Ocker M, Mayr C, Stintzing S, Ritter M, Kiesslich T, et al. Ferroptosis in hepatocellular carcinoma: mechanisms, drug targets and approaches to clinical translation. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14071826.","journal-title":"Cancers (Basel)"},{"key":"450_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1207496","volume":"14","author":"L Guo","year":"2023","unstructured":"Guo L, Hu C, Yao M, Han G. Mechanism of sorafenib resistance associated with ferroptosis in HCC. Front Pharmacol. 2023;14:1207496. https:\/\/doi.org\/10.3389\/fphar.2023.1207496.","journal-title":"Front Pharmacol"},{"issue":"7","key":"450_CR38","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/s41418-023-01166-5","volume":"30","author":"YX Xiong","year":"2023","unstructured":"Xiong YX, Zhang XC, Zhu JH, Zhang YX, Pan YL, Wu Y, et al. Collagen I-DDR1 signaling promotes hepatocellular carcinoma cell stemness via Hippo signaling repression. Cell Death Differ. 2023;30(7):1648\u201365. https:\/\/doi.org\/10.1038\/s41418-023-01166-5.","journal-title":"Cell Death Differ"},{"key":"450_CR39","doi-asserted-by":"publisher","unstructured":"Fang Y, Liu W, Tang Z, Ji X, Zhou Y, Song S, et al. Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack. Hepatology. 2023;77(1):109\u201323.https:\/\/doi.org\/10.1002\/hep.32348","DOI":"10.1002\/hep.32348"},{"key":"450_CR40","doi-asserted-by":"publisher","unstructured":"Cluntun AA BR, Lettlova S, Parnell KM, Shankar TS, Diakos NA, Olson KA. The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure. Cell Metab. 2021.https:\/\/doi.org\/10.1016\/j.cmet.2020.12.003","DOI":"10.1016\/j.cmet.2020.12.003"},{"key":"450_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103627","volume":"73","author":"ZH Wang","year":"2021","unstructured":"Wang ZH, Peng WB, Zhang P, Yang XP, Zhou Q. Lactate in the tumour microenvironment: from immune modulation to therapy. EBioMedicine. 2021;73:103627. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103627.","journal-title":"EBioMedicine"},{"issue":"6125","key":"450_CR42","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1126\/science.1228792","volume":"339","author":"I Ben-Sahra","year":"2013","unstructured":"Ben-Sahra I, Howell JJ, Asara JM, Manning BD. Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science. 2013;339(6125):1323\u20138. https:\/\/doi.org\/10.1126\/science.1228792.","journal-title":"Science"},{"key":"450_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abh4271","author":"MDSS Claiborne","year":"2022","unstructured":"Claiborne MDSS, Zhao L, Arwood ML, Sun IM, Wen J, Thompson EA. Persistent CAD activity in memory CD8(+) T cells supports rRNA synthesis and ribosomal biogenesis required at rechallenge. Sci Immunol. 2022. https:\/\/doi.org\/10.1126\/sciimmunol.abh4271.","journal-title":"Sci Immunol"},{"issue":"5","key":"450_CR44","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/hep.20933","volume":"42","author":"J Bruix","year":"2005","unstructured":"Bruix J, Sherman M, Practice Guidelines Committee AAftSoLD. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208\u201336. https:\/\/doi.org\/10.1002\/hep.20933.","journal-title":"Hepatology"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00450-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00450-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00450-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:37:08Z","timestamp":1776407828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00450-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["450"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00450-3","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed following the guidelines of the Institutional Animal Care and Use Committee of Kyungpook National University (Approval no. 2024\u20130391). The use of human HCC tissue samples was approved by the Institutional Review Board of Keimyung University Dongsan Hospital (IRB no. 2024\u201306-033). Written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}